Cargando…
FGF21 induces autophagy‐mediated cholesterol efflux to inhibit atherogenesis via RACK1 up‐regulation
Fibroblast growth factor 21 (FGF21) acts as an anti‐atherosclerotic agent. However, the specific mechanisms governing this regulatory activity are unclear. Autophagy is a highly conserved cell stress response which regulates atherosclerosis (AS) by reducing lipid droplet degradation in foam cells. W...
Autores principales: | Xiaolong, Lin, Dongmin, Guo, Liu, Mihua, Zuo, Wang, Huijun, Hu, Qiufen, Tan, XueMei, Hu, Wensheng, Lin, Yuping, Pan, Jun, Lin, Zhaolin, Zeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205825/ https://www.ncbi.nlm.nih.gov/pubmed/32227589 http://dx.doi.org/10.1111/jcmm.15118 |
Ejemplares similares
-
Transcriptional regulation of macrophage cholesterol efflux and atherogenesis by a long noncoding RNA
por: Sallam, Tamer, et al.
Publicado: (2018) -
Infliximab Reverses Suppression of Cholesterol Efflux Proteins by TNF-α: A Possible Mechanism for Modulation of Atherogenesis
por: Voloshyna, Iryna, et al.
Publicado: (2014) -
Methotrexate in Atherogenesis and Cholesterol Metabolism
por: Coomes, Eric, et al.
Publicado: (2011) -
Metformin promotes cholesterol efflux in macrophages by up-regulating FGF21 expression: a novel anti-atherosclerotic mechanism
por: Luo, Fei, et al.
Publicado: (2016) -
Cholesterol in the Cell Membrane—An Emerging Player in Atherogenesis
por: Paukner, Karel, et al.
Publicado: (2022)